In 2018, Melodie Narain-Blackwell was 36 years old when she was diagnosed with Crohn’s disease. She suffered with the debilitating symptoms for years before …
Disparity in diagnosis and drugs: Crohn’s and colitis for people of color Read More »
Crohn’s disease and ulcerative colitis, the most common types of inflammatory bowel diseases (IBDs), are incurable, painful, and poorly understood conditions that impact approximately …
How Crohn’s and Colitis Awareness Week helps patients tell their stories Read More »
In Africa, cancer is 60% deadlier than malaria—and without action, the continent’s cancer burden is projected to get worse. We look at how biotechnology …
In Africa, cancer is deadlier than malaria – here’s what biotech’s doing about it Read More »
It’s the biggest vaccination campaign in American history—but not everyone’s on board. Phyllis Arthur, BIO’s VP of Infectious Diseases and Emerging Science, investigates why …
As the world continues to deal with the impact of the COVID-19 pandemic, there remain many illnesses that require research and attention, including orphan …
New hope for rare disease patients with founding of non-profit with for-profit model Read More »
To combat rising Delta cases nationwide, several states (and the federal government) are bringing back mask mandates and implementing vaccine mandates. Many others, however, are …
Good Day BIO readers know climate change is a public health issue—and now, the Biden administration is officially recognizing it, too. The news: The Department …
In an unprecedented coordinated action, more than 200 medical journals published a joint editorial calling climate change our most pressing health challenge and urging UN members …
Medical journals make unprecedented plea for climate action Read More »
November is FOXG1 Awareness Month—so we are amplifying some information from the FOXG1 Research Foundation about why this rare disease is prime for investment. …
FOXG1 Awareness Month—and the need for investment in rare diseases like it Read More »
Boosters for all adults are here. Everyone over 18 “may” receive a booster shot six months after receiving their second Pfizer-BioNTech or Moderna shot, …
